Results 1 to 10 of about 788,113 (355)

Delayed wound repair in sepsis is associated with reduced local pro-inflammatory cytokine expression [PDF]

open access: yes, 2013
Sepsis is one of the main causes for morbidity and mortality in hospitalized patients. Moreover, sepsis associated complications involving impaired wound healing are common.
Albig, Michael   +7 more
core   +10 more sources

Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa

open access: yesCase Reports in Dermatology, 2023
Increasing evidence suggests an association between chronic inflammatory conditions and oral health. Herein, we present a case of a 35-year-old woman with concomitant hidradenitis suppurativa (HS) and periodontitis, who was treated successfully with ...
Yiqiu Yao   +4 more
doaj   +1 more source

Disease‐ and treatment‐related expectations, attitudes, and beliefs among adult patients initiating or switching biological therapies for psoriasis

open access: yesJEADV Clinical Practice, 2023
Background The treatment expectations of patients with psoriasis are essential for clinical outcomes. Objectives To examine disease‐ and treatment related intra‐ and interpersonal factors and their relation to treatment expectations among patients with ...
Maria Clemmesen   +7 more
doaj   +1 more source

Pedal gangrene in a patient with COVID-19 treated with prone positioning and extracorporeal membrane oxygenation

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2021
Many patients hospitalized with coronavirus disease 2019 are treated with venovenous extracorporeal membrane oxygenation and prone positioning to optimize oxygenation.
Amanda Siegel, DPM   +5 more
doaj   +1 more source

The epidemiological characteristic and trends of burns globally

open access: yesBMC Public Health, 2022
Background Burns is a type of injury, caused by unintentional exposure to substances of high temperature, including hot liquid, solid, and objects radiating heat energy, placing a high burden not only on patients’ families but also on national healthcare
Aobuliaximu Yakupu   +5 more
doaj   +1 more source

Multi-function based modeling of 3D heterogeneous wound scaffolds for improved wound healing [PDF]

open access: yes, 2010
This paper presents a new multi-function based modeling of 3D heterogeneous porous wound scaffolds to improve wound healing process for complex deep acute or chronic wounds.
Koc, Bahattin   +3 more
core   +2 more sources

Cluster analysis identifies six clinical subtypes of hidradenitis suppurativa characterised by distinct comorbidities, inflammatory and metabolic profiles, patient‐reported outcomes and treatment patterns

open access: yesJEADV Clinical Practice, 2023
Background Sub‐classification of hidradenitis suppurativa (HS) may allow for a better understanding of disease aetiology and disease burden, and eventually permit a more personalised treatment for patients.
Astrid‐Helene R. Jørgensen   +7 more
doaj   +1 more source

The Importance of Hydration in Wound Healing: Reinvigorating the clinical perspective [PDF]

open access: yes, 2016
Balancing skin hydration levels is important as any disruption in skin integrity will result in disturbance of the dermal water balance. The discovery that a moist wound healing environment actively supports the healing response when compared to a dry ...
Atiyeh B.S.   +14 more
core   +1 more source

Endovascular therapy with intravascular ultrasound guidance for popliteal artery occlusion due to blunt trauma

open access: yesEJVES Short Reports, 2015
Background: Historically, popliteal artery occlusion due to blunt trauma has led to high amputation rate and been thought that indication for traditional open operative repair in almost all of cases.
Makoto Utsunomiya   +7 more
doaj   +1 more source

Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety

open access: yesClinical Case Reports, 2020
Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
Astrid‐Helene Ravn Jørgensen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy